Search

Home > Power Lunch > Trial and Error, High-End Holding Up? 12/1/23
Podcast: Power Lunch
Episode:

Trial and Error, High-End Holding Up? 12/1/23
Category: Business
Duration: 00:43:54
Publish Date: 2023-12-01 20:26:04
Description:

Pfizer’s effort to join the weight-loss drug craze just hit a major setback. Patients are quitting its trial after experiencing unpleasant side effects. We’ll bring you the details, and the stock reaction.

Plus, our Retail Ecosystem series concludes with a look at luxury stocks. Is the high-end consumer still buying, or spending money elsewhere on things like experiences? We’ll ask an industry insider.
Total Play: 0

Some more Podcasts by CNBC

50+ Episodes
Strange Succ .. 3     1
1K+ Episodes
Closing Bell     1
1K+ Episodes
Nightly Busi .. 30+     7
200+ Episodes
The Keynote ..     5
2K+ Episodes
CNBC's "Fast .. 200+     20+
400+ Episodes
Fortt Knox 1     1
500+ Episodes
CNBC's "Opti .. 20+     4
1K+ Episodes
CNBC's "On t .. 10+     8